| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Departments of Molecular Biology and Genetics,
2 Comparative Medicine, and
3 Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
To examine the role of ataxia-telangiectasia mutated (Atm) in telomere function, we generated Atm and telomerase null mice (Atm-/- mTR-/- iG6 mice). These mice exhibited increased germ cell death and chromosome fusions compared with either Atm-/- or mTR-/- iG6 mice. Furthermore, the Atm-/- mTR-- iG6 mice had a delayed onset and reduced incidence of thymic lymphoma compared with Atm-/- mice. The tumors in the Atm-/- mTR-/- iG6 mice showed increased apoptosis and anaphase bridges. Finally, lymphomas from Atm-/- mTR-/- iG6 mice were derived from CD8 immature, single-positive T cells, whereas Atm-/- lymphomas were from CD4+CD8+ double-positive T cells. We propose that Atm protects short telomeres and that Atm deficiency cooperates with short telomeres, leading to increased cell death, decreased tumorigenesis, and increased overall survival.
This article has been cited by other articles:
![]() |
L. Vespa, R. T. Warrington, P. Mokros, J. Siroky, and D. E. Shippen ATM regulates the length of individual telomere tracts in Arabidopsis PNAS, November 13, 2007; 104(46): 18145 - 18150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Khoo, D. R. Carrasco, M. W. Bosenberg, J.-H. Paik, and R. A. DePinho Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse PNAS, March 6, 2007; 104(10): 3931 - 3936. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Churikov, C. Wei, and C. M. Price Vertebrate POT1 Restricts G-Overhang Length and Prevents Activation of a Telomeric DNA Damage Checkpoint but Is Dispensable for Overhang Protection. Mol. Cell. Biol., September 1, 2006; 26(18): 6971 - 6982. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Farazi, J. Glickman, J. Horner, and R. A. DePinho Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression. Cancer Res., May 1, 2006; 66(9): 4766 - 4773. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feldser, M. A. Strong, and C. W. Greider Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres PNAS, February 14, 2006; 103(7): 2249 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, D. Srikanta, L. Fanti, S. Pimpinelli, R. Badugu, R. Kellum, and Y. S. Rong Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance PNAS, October 18, 2005; 102(42): 15167 - 15172. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vespa, M. Couvillion, E. Spangler, and D. E. Shippen ATM and ATR make distinct contributions to chromosome end protection and the maintenance of telomeric DNA in Arabidopsis Genes & Dev., September 15, 2005; 19(18): 2111 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Hao, M. A. Strong, and C. W. Greider Phosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts J. Biol. Chem., October 22, 2004; 279(43): 45148 - 45154. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |